Comparison of Arthrogenic Muscle Inhibition (AMI) After ACL Reconstruction in Patients With Conventional Rehabilitation or Conventional Rehabilitation Combined With Digital Therapy

Recruiting N/A Interventional Study
ACL - Anterior Cruciate Ligament Rupture
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
448 (estimated)
Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Traumatic injury to the knee joint, such as rupture of the anterior cruciate ligament (ACL), can compromise the voluntary activation capacity of the quadriceps despite the anatomical integrity of the nerve and muscle structures responsible for contraction. This phenomenon is commonly known as 'arthrogenic muscle inhibition' (AMI). AMI is a major limiting factor in recovery and rehabilitation afte…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patient, male or female, aged ≥ 18 years * Patient with a scheduled primary ACL reconstruction * Patient with a smartphone and able to use a mobile application on a smartphone * Patient affiliated to or benefiting from a social security scheme * French-speaking patient who has…
Contacts

Benjamin FREYCHET, MD

+33437530708

benjamin.freychet@gmail.com

CONTACT